pappas-small-logo

Us2.ai Secures US$15M Series A To…

SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
Read More
Investor Login
Pappas CapitalPappas CapitalPappas CapitalPappas Capital
  • Home
  • About 
    • About Us
    • News & Events
    • For Entrepreneurs
    • Contact Us
  • Team
  • Portfolio
  • Ventures
  • Specialized Fund Management 
    • About
    • Chiesi Ventures Fund
    • Asia Innovation Ventures
    • AgTech Initiatives
    • Specialized Holdings
  • Translational Medicine 
    • About
    • Wake Forest Technology Development Program

logo_white
  • Home
  • About
  • Team
  • Portfolio
  • News & Events
  • Contact
  • Ventures
  • Specialized Funds
  • Translational Medicine
NVCA
bio
nc-biotech

© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.

Investor Login
Investor Login

© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.